EXOZ eXoZymes Inc.

Price (delayed)

$6.38

Market cap

$59.22M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.19

Enterprise value

$54.65M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 1

Invizyne Technologies, Inc. is a cell-free enzyme-based biomanufacturing technology company headquartered in Monrovia, California. Invizyne is redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources ...

Highlights
The debt has contracted by 22% YoY and by 7% from the previous quarter
eXoZymes's equity has soared by 139% from the previous quarter but it has decreased by 49% YoY
eXoZymes's quick ratio has decreased by 39% YoY
eXoZymes's net income has decreased by 32% YoY and by 5% from the previous quarter

Key stats

What are the main financial stats of EXOZ

EXOZ stock price

How has the eXoZymes stock price performed over time
Intraday
3.07%
1 week
3.57%
1 month
-10.77%
1 year
-56.3%
YTD
-41.47%
QTD
-24.32%

Financial performance

How have eXoZymes's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.56M
Net income
-$10.19M
Gross margin
N/A
Net margin
N/A
eXoZymes's net income has decreased by 32% YoY and by 5% from the previous quarter
eXoZymes's operating income has decreased by 30% YoY and by 4% from the previous quarter

Price vs fundamentals

How does EXOZ's price correlate with its fundamentals

Growth

What is eXoZymes's growth rate over time

Valuation

What is eXoZymes stock price valuation
P/E
N/A
P/B
14.8
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 17% YoY and by 4.4% from the previous quarter
eXoZymes's equity has soared by 139% from the previous quarter but it has decreased by 49% YoY
The P/B is 48% below the last 4 quarters average of 27.7

Efficiency

How efficient is eXoZymes business performance
The ROE has plunged by 117% YoY and by 32% from the previous quarter
EXOZ's ROA has plunged by 94% YoY and by 12% from the previous quarter
eXoZymes's ROIC has plunged by 75% YoY and by 18% from the previous quarter

Dividends

What is EXOZ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EXOZ.

Financial health

How did eXoZymes financials performed over time
eXoZymes's total assets is 84% more than its total liabilities
The current ratio has soared by 189% from the previous quarter but it is down by 38% YoY
eXoZymes's total assets has soared by 99% from the previous quarter but it has decreased by 18% YoY
The debt is 70% less than the equity
eXoZymes's equity has soared by 139% from the previous quarter but it has decreased by 49% YoY
EXOZ's debt to equity has shrunk by 61% QoQ but it has soared by 58% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.